Question
Microfilaria
Answer
Microfilariae are the motile, immature (larval) stage of filarial nematodes (e.g., Wuchereria bancrofti, Brugia malayi, Loa loa), released by adult female worms into the host’s blood or tissue fluid, and constituting the diagnostic/transmissible stage picked up by the arthropod vector to continue the parasite’s life cycle.
Structure: thin, thread-like larvae, typically sheathed (retaining the egg shell as a loose sheath — a key identifying feature for W. bancrofti and B. malayi) or unsheathed (e.g., Loa loa, Mansonella species), with an internal column of somatic nuclei whose arrangement, along with the presence/absence and staining characteristics of the sheath, and the presence/position of specific nuclei at the tail tip, allows species identification on stained blood smear.
Periodicity: many filarial species show a characteristic periodicity — a pattern of peak microfilarial concentration in peripheral blood at specific times of day, synchronized with the biting habits of their specific vector, to maximize transmission efficiency:
- Wuchereria bancrofti (most strains) — nocturnal periodicity, with peak numbers in peripheral blood at night (matching the night-biting habit of its Culex mosquito vector); blood samples for diagnosis are therefore classically collected around midnight.
- Some Pacific strains of W. bancrofti — show subperiodic (diurnal-subperiodic) patterns, correlating with day-biting vector species in those regions.
- Loa loa — shows diurnal periodicity (peak in daytime blood, matching its day-biting Chrysops fly vector).
Laboratory diagnosis: thick blood smear microscopy (Giemsa or haematoxylin stain) is the standard method, timed to the specific parasite’s known periodicity for that region; concentration techniques (e.g., Knott’s concentration method, membrane filtration) improve sensitivity for low-density infections; antigen detection tests (for W. bancrofti circulating filarial antigen) are available and are not subject to periodicity constraints, allowing testing at any time of day.
Clinical significance: microfilaraemia itself is often asymptomatic, but the presence and load of microfilariae are relevant to disease transmission dynamics, treatment planning (risk of adverse reactions with rapid microfilarial killing by certain drugs, e.g., diethylcarbamazine, in heavily infected individuals), and elimination programme monitoring (e.g., WHO’s Global Programme to Eliminate Lymphatic Filariasis).